Benefits of Improved Vehicle of Dermatological Steroidal Treatments

EP: 1.Expert Opinions on the Role of Corticosteroids in Dermatological Conditions

EP: 2.Practical Insights on Potency, Formulation, Administration and Utility of Topical Corticosteroids

EP: 3.Atopic Dermatitis and Plaque Psoriasis Topical Treatment Considerations

EP: 4.A Conversation on Topical Corticosteroid Hesitancy

EP: 5.Clinical Trials of Steroidal and Nonsteroidal Treatment

EP: 6.Steroidal and Nonsteroidal Treatment Options for Dermatologic Conditions

Now Viewing

EP: 7.Benefits of Improved Vehicle of Dermatological Steroidal Treatments

EP: 8.Importance of Educating Patients on Topical Corticosteroid Application

EP: 9.Frontline Forum Part 1: Topical Therapy for Corticosteroid-Responsive Dermatoses

EP: 10.Frontline Forum Part 2: Topical Therapy for Corticosteroid-Responsive Dermatoses

EP: 11.Frontline Forum Part 3: Topical Therapy for Corticosteroid-Responsive Dermatoses

EP: 12.Discovering Dermatology Times: November 2023 Corticosteroid-Responsive Dermatoses Supplement

Linda F. Stein Gold, MD: As you mentioned, patients especially…they want to use a steroid, they might use it on larger body surface areas. We do have and we talked about…the fact that we now have more sophisticated…designer vehicles…where we get more of [those] depot effects, where we don’t see the drug really transitioning all the way through the epidermis but more staying at the site of action as opposed to just going rapidly through and into the systemic circulation. Do either of you find value in that?

Darren West, MPAS, PA-C: [A]bsolutely. But…that’s why…today we’re more comfortable writing [prescriptions for] steroids as well as they’re just better…. The vehicle will matter...in many instances. Unfortunately, I can’t get great products for all my patients, but those I can get them to, I love those newer products. And yes, it’s more effective, it’s safer. And I know I worry much less about any of those secondary [adverse] effects because of it.

Linda F. Stein Gold, MD: Jayme, do you agree?

Jayme M. Heim, MSN, FNP-BC: I agree. They’re using it for a shorter duration of time. They’re much more effective. And [there is] the fact that they’re actually more cosmetically elegant for the patients—[for] patients to not have grease all over everything, all over their clothing or else…they have a screen that’s just sitting on their skin the whole time, and it’s really not doing what it really effectively needs to do. So, our new agents…are nice. But like Darren said…not all our patients get access to that type of medication.

Linda F. Stein Gold, MD: I agree with you both…. [W]hen somebody comes in and they have an acute problem, they have contact dermatitis, I know it’s going to go away no matter what I give them; I’m often going to pick a generic that’s going to be cheap and easy. It’s those patients who have those chronic diseases where I know that they’re going to have to put on a medication in bursts over the course of time. That’s one [instance where] I’m a little more selective and really looking for a drug with more of a designer vehicle that I know potentially is safer for the long term, more cosmetically [elegant]. I might have to fight a little bit more with insurance. But I think for a chronic condition…patients appreciate it a little bit more.

Transcript is AI-generated and edited for clarity and readability.